On October 23, 2008, Skura Corporation, the leader in next generation software in Closed-Loop Marketing (CLM) for the Life Sciences Industry spun off most of its professional and CRM analytics consulting business to IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries.

Skura and IMS Health are confident that this transaction has significant benefits for both companies, allowing both organizations to strengthen their positions in their respective markets.

As a result of this move, Skura will now focus on developing innovative next generation software for sales and marketing applications targeting Life Sciences and Pharmaceutical manufacturers. In March of 2006 Skura launched the first CLM software application with advanced analytical and predictive modeling setting a new industry standard. The SFX CLM Suite™ is also recognized by leading industry analysts as “next generation” with unique analytical capabilities.

Skura is already very well positioned as the market leader in terms of license revenue and R&D “investment”. This very important strategic development will solidify Skura's relationship with IMS as a Global Skura SFX implementation partner.

For more information about IMS Health, click here.